Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Endometrial cancer | R-HSA-2077421 | map05213 | monastrol | 610479 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | monastrol | 610479 | drug-path |
| Glioma | Q9NZM4 | map05214 | sulindac sulfide | 31703 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | sulindac sulfide | 31703 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | sulindac sulfide | 31703 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | sulindac sulfide | 31703 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | sulindac sulfide | 31703 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | sulindac sulfide | 31703 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulindac sulfide | 31703 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | exisulind | 3655 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | exisulind | 3655 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | exisulind | 3655 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | exisulind | 3655 | drug-path |
| Asthma | R-HSA-444620 | map05310 | exisulind | 3655 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | exisulind | 3655 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | exisulind | 3655 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | exisulind | 3655 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | exisulind | 3655 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | exisulind | 3655 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | exisulind | 3655 | drug-path |